Liquidia LQDA
NASDAQ LQDA
$68.32 +0.64 (+0.95%)
As of: Sep 9, 2026 · 2:20 PM EDT

Liquidia (LQDA) Non Operating Interest Expenses (2020 - 2026)

Liquidia (LQDA) posted Non Operating Interest Expenses of $6.3 million for Q2 2026, down 3.05% on a QoQ basis from $6.5 million in Q1 2026, and up 11.28% year-over-year from $5.7 million in Q2 2025.

Analysis

Liquidia (LQDA) Non Operating Interest Expenses (2020 - 2026) Analysis & Trends

Liquidia has reported Non Operating Interest Expenses for 7 years, with the latest figure at $6.3 million in Q2 2026.

  • On a quarterly basis, Non Operating Interest Expenses rose 11.28% year-over-year to $6.3 million in Q2 2026; TTM through Jun 2026 was $26.6 million, a 44.04% increase from a year earlier, with the FY2025 full-year figure at $24.2 million, up 64.99% from the prior year.
  • Non Operating Interest Expenses was $6.3 million for Q2 2026 at Liquidia, down from $6.5 million in the prior quarter.
  • The five-year high for Non Operating Interest Expenses was $6.9 million in Q3 2025, with the low at $478000.0 in Q1 2022.
  • Average Non Operating Interest Expenses over 5 years is $3.3 million, with a median of $3.2 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2026: Non Operating Interest Expenses jumped 242.16% in 2022, then advanced 11.28% in 2026.
  • Over 5 years, Non Operating Interest Expenses stood at $698000.0 in 2022, then jumped by 181.09% to $2.0 million in 2023, then surged by 129.71% to $4.5 million in 2024, then surged by 53.07% to $6.9 million in 2025, then declined by 8.74% to $6.3 million in 2026.
  • The last three Non Operating Interest Expenses figures came in at $6.3 million (Q2 2026), $6.5 million (Q1 2026), and $6.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 646.62 Bn 625.86 Bn 17.26 Bn 281.00 Mn
2 AbbVie 442.20 Bn 435.63 Bn 12.70 Bn -
3 Merck 366.42 Bn 359.28 Bn 12.21 Bn -
4 Novartis Ag 266.80 Bn 259.11 Bn 11.24 Bn -462.00 Mn
5 Pfizer 159.12 Bn 147.42 Bn 10.94 Bn -
6 Sanofi 52.46 Bn 45.08 Bn 10.79 Bn -333.60 Mn
7 Revolution Medicines 44.08 Bn 44.08 Bn - 23.78 Mn
8 Incyte 25.39 Bn 20.85 Bn 1.57 Bn 582,000.00
9 United Therapeutics 21.45 Bn 18.78 Bn 683.80 Mn 2.90 Mn
10 Liquidia 6.07 Bn 5.79 Bn 160.92 Mn 6.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.30 Mn
Mar 31, 2026 6.49 Mn
Dec 31, 2025 6.90 Mn
Sep 30, 2025 6.95 Mn
Jun 30, 2025 5.66 Mn
Mar 31, 2025 4.67 Mn
Dec 31, 2024 4.51 Mn
Sep 30, 2024 3.66 Mn
Jun 30, 2024 3.33 Mn
Mar 31, 2024 3.16 Mn
Dec 31, 2023 1.96 Mn
Sep 30, 2023 1.76 Mn
Jun 30, 2023 1.43 Mn
Mar 31, 2023 1.12 Mn
Dec 31, 2022 698,000.00
Sep 30, 2022 620,000.00
Jun 30, 2022 542,000.00
Mar 31, 2022 478,000.00
Dec 31, 2021 204,000.00
Sep 30, 2021 205,000.00